TNFRSF9 and cancer: The report also examined CD137+ TILs in 6 different cancers and HCC had the highest number of CD137+ TILs in the examined tumors (ovarian cancer, NSCLC, intrahepatic cholangiocarcinoma, colorectal cancer and glioblastoma) [23].